Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precancerous Conditions 3Neuroblastoma 3Skin Neoplasms 2Prostatic Neoplasms 2Carcinoma, Basal Cell 2Adenomatous Polyposis Coli 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Non-melanoma Skin Cancer 1Keratosis, Actinic 1Gastritis, Atrophic 1Esophageal Neoplasms 1Colorectal Neoplasms 1Adenomatous Polyps 1

Interventions

Gastroscopy 2Rabeprazole 1Proton Pump Inhibitors 1Pantoprazole 1Lansoprazole 1Endoscopy, Digestive System 1Eflornithine 1Dexlansoprazole 1Colonoscopy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastritis, Atrophic × Eflornithine × Clear all
NCT02794428 2024-10-16

Chemoprevention of Gastric Carcinogenesis

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
91 enrolled 10 charts
Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡